Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.55 USD | -4.31% | +9.23% | -4.31% | +17.55% | 120.78 M USD | ||
| 3854 |  VANI Vivani Medical, Inc. - Common Stock | 1.36 USD | -1.45% | -1.45% | +4.62% | +9.68% | 122.68 M USD | ||
| 3855 |  GUTS Fractyl Health, Inc. - Common Stock | 0.76 USD | -2.56% | +11.76% | -3.80% | -24.00% | 120.98 M USD | ||
| 3856 |  GNLX Genelux Corporation - Common Stock | 2.58 USD | -5.15% | -3.73% | -12.84% | -31.56% | 116.73 M USD | ||
| 3858 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +7.41% | +6.10% | +40.32% | 121.27 M USD | ||
| 3864 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.18 USD | 0.00% | +5.36% | +20.41% | -39.49% | 122.01 M USD | ||
| 3867 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.77 USD | +1.92% | +20.15% | +39.07% | -45.61% | 123.72 M USD | ||
| 3870 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.90 USD | -5.26% | +1.12% | -47.37% | +28.57% | 114.53 M USD | ||
| 3877 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.77 USD | -0.56% | +3.51% | -4.32% | -78.93% | 118.57 M USD | ||
| 3890 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.80 USD | -1.44% | +2.78% | +10.85% | -32.87% | 112.60 M USD | ||
| 3896 |  SEER Seer, Inc. - Class A Common Stock | 2.03 USD | 0.00% | 0.00% | +2.53% | -2.40% | 112.41 M USD | ||
| 3911 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.81 USD | -3.57% | -2.41% | +1.25% | -19.80% | 103.28 M USD | ||
| 3947 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.68 USD | +22.63% | +25.37% | +33.33% | -9.19% | 121.77 M USD | ||
| 3950 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.06 USD | -2.17% | -1.46% | +8.27% | -60.31% | 96.65 M USD | ||
| 3955 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.57 USD | -1.34% | +21.91% | +18.73% | -35.12% | 96.06 M USD | ||
| 3962 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.88 USD | +0.35% | +1.41% | -14.29% | +26.32% | 96.05 M USD | ||
| 3967 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -2.97% | +4.26% | -68.99% | 93.19 M USD | ||
| 3969 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.12 USD | -4.07% | +4.95% | +30.86% | +58.21% | 90.85 M USD | ||
| 3979 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.08 USD | -0.39% | +7.17% | +28.61% | +47.25% | 92.48 M USD | ||
| 3989 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.50 USD | -1.32% | -3.23% | -1.96% | -74.23% | 90.49 M USD |
Nouvelles Biotechnology Stocks
Deutsche Bank dégrade argenx de Achat à Conserver en raison de la valorisation
Pourquoi l’action Monte Rosa Therapeutics chute-t-elle aujourd’hui ?
L’action Biomea Fusion bondit après la fin du recrutement pour son essai sur le diabète
L’action Monte Rosa chute au lancement d’une étude de phase 2 sur le cancer de la prostate
L’action Crinetics Pharmaceuticals atteint un record historique à 84,8 USD
H.C. Wainwright maintient sa recommandation sur Biomea Fusion après l’enrôlement
La FDA prolonge l’examen du deramiocel de Capricor au 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |